{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:49:53Z","timestamp":1793857793620,"version":"4.6.1"},"reference-count":232,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2019,12,22]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medications, but they are associated with a number of serious adverse effects, including hypertension, cardiovascular disease, kidney injury and GI complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To develop a set of multidisciplinary recommendations for the safe prescription of NSAIDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Randomised control trials and observational studies published before January 2018 were reviewed, with 329 papers included for the synthesis of evidence-based recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Whenever possible, a NSAID should be avoided in patients with treatment-resistant hypertension, high risk of cardiovascular disease and severe chronic kidney disease (CKD). Before treatment with a NSAID is started, blood pressure should be measured, unrecognised CKD should be screened in high risk cases, and unexplained iron-deficiency anaemia should be investigated. For patients with high cardiovascular risk, and if NSAID treatment cannot be avoided, naproxen or celecoxib are preferred. For patients with a moderate risk of peptic ulcer disease, monotherapy with a non-selective NSAID plus a proton pump inhibitor (PPI), or a selective cyclo-oxygenase-2 (COX-2) inhibitor should be used; for those with a high risk of peptic ulcer disease, a selective COX-2 inhibitor plus PPI are needed. For patients with pre-existing hypertension receiving renin-angiotensin system blockers, empirical addition (or increase in the dose) of an antihypertensive agent of a different class should be considered. Blood pressure and renal function should be monitored in most cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NSAIDs are a valuable armamentarium in clinical medicine, but appropriate recognition of high-risk cases, selection of a specific agent, choice of ulcer prophylaxis and monitoring after therapy are necessary to minimise the risk of adverse events.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2019-319300","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T17:31:24Z","timestamp":1579023084000},"page":"617-629","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":130,"title":["Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE\/APLAR\/APSDE\/APSH\/APSN\/PoA recommendations"],"prefix":"10.1136","volume":"69","author":[{"given":"Cheuk-Chun","family":"Szeto","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics, Chinese University of Hong Kong, New Territories, Hong Kong"},{"name":"Asian Pacific Society of Nephrology (APSN), Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sugano","sequence":"additional","affiliation":[{"name":"Jichi Medical University, Shimotsuke, Tochigi, Japan"},{"name":"Asian Pacific Association of Gastroenterology (APAGE), Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Guang","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Hypertension, Shanghai, Shanghai, China"},{"name":"Asia Pacific Society of Hypertension (APSH), Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuma","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Saga University, Saga, Japan"},{"name":"Asia-Pacific Society for Digestive Endoscopy (APSDE), Saga, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Whittle","sequence":"additional","affiliation":[{"name":"The University of Adelaide, Adelaide, South Australia, Australia"},{"name":"Asia Pacific League of Associations for Rheumatology (APLAR), Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopesh K","family":"Modi","sequence":"additional","affiliation":[{"name":"Asian Pacific Society of Nephrology (APSN), Hong Kong, Hong Kong"},{"name":"Samarpan Kidney Institute and Research Center, Bhopal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Huen","family":"Chen","sequence":"additional","affiliation":[{"name":"National Yang-Ming University, Taipei, Taiwan"},{"name":"Pulse of Asia (PoA), Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Bae","family":"Park","sequence":"additional","affiliation":[{"name":"Pulse of Asia (PoA), Taipei, Taiwan"},{"name":"JB Lab and Clinic and Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-Shan","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Chinese University of Hong Kong, New Territories, Hong Kong"},{"name":"Asia Pacific League of Associations for Rheumatology (APLAR), Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriengsak","family":"Vareesangthip","sequence":"additional","affiliation":[{"name":"Asian Pacific Society of Nephrology (APSN), Hong Kong, Hong Kong"},{"name":"Mahidol University, Nakorn Pathom, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5580-7686","authenticated-orcid":false,"given":"Kelvin K F","family":"Tsoi","sequence":"additional","affiliation":[{"name":"Chinese University of Hong Kong, New Territories, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7388-2436","authenticated-orcid":false,"given":"Francis K L","family":"Chan","sequence":"additional","affiliation":[{"name":"Chinese University of Hong Kong, New Territories, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"2025090723515854000_69.4.617.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00627-6"},{"key":"2025090723515854000_69.4.617.2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.755"},{"key":"2025090723515854000_69.4.617.3","doi-asserted-by":"publisher","DOI":"10.1002\/pds.983"},{"key":"2025090723515854000_69.4.617.4","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0306"},{"key":"2025090723515854000_69.4.617.5","doi-asserted-by":"publisher","DOI":"10.1038\/newbio231232a0"},{"key":"2025090723515854000_69.4.617.6","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.207449"},{"key":"2025090723515854000_69.4.617.7","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R800042-JLR200"},{"key":"2025090723515854000_69.4.617.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151027"},{"key":"2025090723515854000_69.4.617.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.028886"},{"key":"2025090723515854000_69.4.617.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011742"},{"key":"2025090723515854000_69.4.617.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"},{"key":"2025090723515854000_69.4.617.12","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12382"},{"key":"2025090723515854000_69.4.617.13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210597"},{"key":"2025090723515854000_69.4.617.14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012087"},{"key":"2025090723515854000_69.4.617.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.08.001"},{"key":"2025090723515854000_69.4.617.16","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199651020-00001"},{"key":"2025090723515854000_69.4.617.17","first-page":"319","article-title":"Nonsteroidal anti-inflammatory drugs and hypertension","volume":"2","author":"Brook","year":"2000","journal-title":"J Clin Hypertens"},{"key":"2025090723515854000_69.4.617.18","first-page":"1301","article-title":"Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease","volume":"18","author":"LeLorier","year":"2002","journal-title":"Can J Cardiol"},{"key":"2025090723515854000_69.4.617.19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.027288"},{"key":"2025090723515854000_69.4.617.20","doi-asserted-by":"publisher","DOI":"10.1177\/2042098617690485"},{"key":"2025090723515854000_69.4.617.21","article-title":"Cardiovascular risk of nonsteroidal anti-inflammatory drugs: an under-recognized public health issue","volume":"9","author":"Varga","year":"2017","journal-title":"Cureus"},{"key":"2025090723515854000_69.4.617.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.01.045"},{"key":"2025090723515854000_69.4.617.23","doi-asserted-by":"publisher","DOI":"10.1097\/00041552-200103000-00001"},{"key":"2025090723515854000_69.4.617.24","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903311023"},{"key":"2025090723515854000_69.4.617.25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.10.049"},{"key":"2025090723515854000_69.4.617.26","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000432"},{"key":"2025090723515854000_69.4.617.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.08.001"},{"key":"2025090723515854000_69.4.617.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv505"},{"key":"2025090723515854000_69.4.617.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000160005.90598.41"},{"key":"2025090723515854000_69.4.617.30","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.115"},{"key":"2025090723515854000_69.4.617.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.002"},{"key":"2025090723515854000_69.4.617.32","doi-asserted-by":"publisher","DOI":"10.1163\/156856005774415565"},{"key":"2025090723515854000_69.4.617.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001388","article-title":"Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries","volume":"10","author":"McGettigan","year":"2013","journal-title":"PLoS Med"},{"key":"2025090723515854000_69.4.617.34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra052717"},{"key":"2025090723515854000_69.4.617.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199405053301808"},{"key":"2025090723515854000_69.4.617.36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3147"},{"key":"2025090723515854000_69.4.617.37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"2025090723515854000_69.4.617.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.005"},{"key":"2025090723515854000_69.4.617.39","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06180616"},{"key":"2025090723515854000_69.4.617.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.189141"},{"key":"2025090723515854000_69.4.617.41","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007"},{"key":"2025090723515854000_69.4.617.42","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-12-93","article-title":"Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension","volume":"12","author":"Aljadhey","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"2025090723515854000_69.4.617.43","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE2007413"},{"key":"2025090723515854000_69.4.617.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01468.x"},{"key":"2025090723515854000_69.4.617.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021907"},{"key":"2025090723515854000_69.4.617.46","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.717528"},{"key":"2025090723515854000_69.4.617.47","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328325d831"},{"key":"2025090723515854000_69.4.617.48","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328302c9fe"},{"key":"2025090723515854000_69.4.617.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2010.02346.x"},{"key":"2025090723515854000_69.4.617.50","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx508"},{"key":"2025090723515854000_69.4.617.51","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.2.161"},{"key":"2025090723515854000_69.4.617.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02661-9"},{"key":"2025090723515854000_69.4.617.53","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001592","article-title":"Network meta-analysis comparing relatively selective COX-2 inhibitors versus coxibs for the prevention of NSAID-induced gastrointestinal injury","volume":"94","author":"Yang","year":"2015","journal-title":"Medicine"},{"key":"2025090723515854000_69.4.617.54","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.5.IOI50013"},{"key":"2025090723515854000_69.4.617.55","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283310dc9"},{"key":"2025090723515854000_69.4.617.56","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X14541668"},{"key":"2025090723515854000_69.4.617.57","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-4-199408150-00011"},{"key":"2025090723515854000_69.4.617.58","doi-asserted-by":"publisher","DOI":"10.1186\/ar1704"},{"key":"2025090723515854000_69.4.617.59","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410040045007"},{"key":"2025090723515854000_69.4.617.60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32203-7"},{"key":"2025090723515854000_69.4.617.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60861-7"},{"key":"2025090723515854000_69.4.617.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-3797(03)00121-1"},{"key":"2025090723515854000_69.4.617.63","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-11-200712040-00010"},{"key":"2025090723515854000_69.4.617.64","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d442","article-title":"Improving cardiovascular health at population level: 39 community cluster randomised trial of cardiovascular health awareness program (CHAP)","volume":"342","author":"Kaczorowski","year":"2011","journal-title":"BMJ"},{"key":"2025090723515854000_69.4.617.65","unstructured":"U.S. Preventive Services Task Force . Final recommendation statement. Hypertension in adults: screening and home monitoring. Available: http: \/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/RecommendationStatementFinal\/high-blood-pressure-in-adults-screening [Accessed 13 Dec 2018]."},{"key":"2025090723515854000_69.4.617.66","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000597"},{"key":"2025090723515854000_69.4.617.67","first-page":"927","article-title":"Recommendations on screening for high blood pressure in Canadian adults","volume":"59","author":"Lindsay","year":"2013","journal-title":"Can Fam Physician"},{"key":"2025090723515854000_69.4.617.68","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001940"},{"key":"2025090723515854000_69.4.617.69","first-page":"e736","article-title":"An analysis of blood pressure screening results worldwide","volume":"2018","author":"Beaney","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025090723515854000_69.4.617.70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054309","article-title":"Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study","volume":"8","author":"Olsen","year":"2013","journal-title":"PLoS One"},{"key":"2025090723515854000_69.4.617.71","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(88)80021-9"},{"key":"2025090723515854000_69.4.617.72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9149(02)02233-6","article-title":"Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema","volume":"89","author":"Frishman","year":"2002","journal-title":"Am J Cardiol"},{"key":"2025090723515854000_69.4.617.73","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.13.jrv60015"},{"key":"2025090723515854000_69.4.617.74","first-page":"e372","article-title":"Interaction between antihypertensives and NSAIDs in primary care: a controlled trial","volume":"15","author":"Pavlicevi\u0107","year":"2008","journal-title":"Can J Clin Pharmacol"},{"key":"2025090723515854000_69.4.617.75","doi-asserted-by":"publisher","DOI":"10.3317\/jraas.2003.023"},{"key":"2025090723515854000_69.4.617.76","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-012-9631-5"},{"key":"2025090723515854000_69.4.617.77","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4857"},{"key":"2025090723515854000_69.4.617.78","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3617"},{"key":"2025090723515854000_69.4.617.79","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-12-1573"},{"key":"2025090723515854000_69.4.617.80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179081","article-title":"The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: a nationwide population-based cohort study","volume":"12","author":"Hung","year":"2017","journal-title":"PLoS One"},{"key":"2025090723515854000_69.4.617.81","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-015-1288-3"},{"key":"2025090723515854000_69.4.617.82","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203137"},{"key":"2025090723515854000_69.4.617.83","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.0809"},{"key":"2025090723515854000_69.4.617.84","doi-asserted-by":"publisher","DOI":"10.1002\/art.23911"},{"key":"2025090723515854000_69.4.617.85","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1909"},{"key":"2025090723515854000_69.4.617.86","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"2025090723515854000_69.4.617.87","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1335-1"},{"key":"2025090723515854000_69.4.617.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.07.019"},{"key":"2025090723515854000_69.4.617.89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med"},{"key":"2025090723515854000_69.4.617.90","first-page":"CD009865","article-title":"Celecoxib for osteoarthritis","volume":"5","author":"Puljak","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090723515854000_69.4.617.91","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"2025090723515854000_69.4.617.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2008.07.013"},{"key":"2025090723515854000_69.4.617.93","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068650"},{"key":"2025090723515854000_69.4.617.94","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ"},{"key":"2025090723515854000_69.4.617.95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.09.012"},{"key":"2025090723515854000_69.4.617.96","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22502"},{"key":"2025090723515854000_69.4.617.97","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-015-0554-0"},{"key":"2025090723515854000_69.4.617.98","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2227"},{"key":"2025090723515854000_69.4.617.99","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3437"},{"key":"2025090723515854000_69.4.617.100","doi-asserted-by":"crossref","DOI":"10.1038\/srep16827","article-title":"Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci Rep"},{"key":"2025090723515854000_69.4.617.101","doi-asserted-by":"crossref","DOI":"10.1038\/srep10593","article-title":"Comparison between 200\u2009mg QD and 100\u2009mg BID oral celecoxib in the treatment of knee or hip osteoarthritis","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci Rep"},{"key":"2025090723515854000_69.4.617.102","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30981-9"},{"key":"2025090723515854000_69.4.617.103","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.467"},{"key":"2025090723515854000_69.4.617.104","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp054"},{"key":"2025090723515854000_69.4.617.105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2011.00283.x"},{"key":"2025090723515854000_69.4.617.106","first-page":"1843","article-title":"Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the standard care vs. celecoxib outcome trial (SCOT)","volume":"38","author":"MacDonald","year":"2017","journal-title":"Eur Heart J"},{"key":"2025090723515854000_69.4.617.107","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611593"},{"key":"2025090723515854000_69.4.617.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.06.028"},{"key":"2025090723515854000_69.4.617.109","first-page":"S19","article-title":"Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis","volume":"92","author":"Turajane","year":"2009","journal-title":"J Med Assoc Thai"},{"key":"2025090723515854000_69.4.617.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.03.008"},{"key":"2025090723515854000_69.4.617.111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011233432103"},{"key":"2025090723515854000_69.4.617.112","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.13.jrv60011"},{"key":"2025090723515854000_69.4.617.113","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001362","article-title":"Increased risk of end-stage renal disease (ESRD) requiring chronic dialysis is associated with use of nonsteroidal anti-inflammatory drugs (NSAIDs)","volume":"94","author":"Chang","year":"2015","journal-title":"Medicine"},{"key":"2025090723515854000_69.4.617.114","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002645","article-title":"Adverse effects of oral nonselective and cyclooxygenase-2-selective NSAIDs on hospitalization for acute kidney injury","volume":"95","author":"Chou","year":"2016","journal-title":"Medicine"},{"key":"2025090723515854000_69.4.617.115","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.05105"},{"key":"2025090723515854000_69.4.617.116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122899","article-title":"Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study","volume":"10","author":"Ingrasciotta","year":"2015","journal-title":"PLoS One"},{"key":"2025090723515854000_69.4.617.117","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S121698"},{"key":"2025090723515854000_69.4.617.118","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1798"},{"key":"2025090723515854000_69.4.617.119","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study","volume":"346","author":"Lapi","year":"2012","journal-title":"BMJ"},{"key":"2025090723515854000_69.4.617.120","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204078"},{"key":"2025090723515854000_69.4.617.121","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005581","article-title":"Analgesia dose prescribing and estimated glomerular filtration rate decline: a general practice database linkage cohort study","volume":"4","author":"Nderitu","year":"2014","journal-title":"BMJ Open"},{"key":"2025090723515854000_69.4.617.122","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cms086"},{"key":"2025090723515854000_69.4.617.123","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol"},{"key":"2025090723515854000_69.4.617.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.04.031"},{"key":"2025090723515854000_69.4.617.125","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.74"},{"key":"2025090723515854000_69.4.617.126","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00830110"},{"key":"2025090723515854000_69.4.617.127","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq011"},{"key":"2025090723515854000_69.4.617.128","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2016.05.005"},{"key":"2025090723515854000_69.4.617.129","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000441051.36783.f3"},{"key":"2025090723515854000_69.4.617.130","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01690309"},{"key":"2025090723515854000_69.4.617.131","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199010000-00007"},{"key":"2025090723515854000_69.4.617.132","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.101"},{"key":"2025090723515854000_69.4.617.133","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1264"},{"key":"2025090723515854000_69.4.617.134","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70011-9"},{"key":"2025090723515854000_69.4.617.135","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2013.00075"},{"key":"2025090723515854000_69.4.617.136","first-page":"21","article-title":"Chronic kidney disease: identification and management in primary care","volume":"7","author":"Fraser","year":"2016","journal-title":"Pragmat Obs Res"},{"key":"2025090723515854000_69.4.617.137","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02250314"},{"key":"2025090723515854000_69.4.617.138","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-8-201210160-00533"},{"key":"2025090723515854000_69.4.617.139","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"2025090723515854000_69.4.617.140","unstructured":"National Clinical Guideline Centre (UK) . Chronic kidney disease (partial update): early identification and management of chronic kidney disease in adults in primary and secondary care. London: National Institute for Health and Care Excellence (UK), 2014."},{"key":"2025090723515854000_69.4.617.141","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12052"},{"key":"2025090723515854000_69.4.617.142","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198809223191206"},{"key":"2025090723515854000_69.4.617.143","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.164"},{"key":"2025090723515854000_69.4.617.144","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh485"},{"key":"2025090723515854000_69.4.617.145","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07630717"},{"key":"2025090723515854000_69.4.617.146","doi-asserted-by":"publisher","DOI":"10.3390\/ph3072291"},{"key":"2025090723515854000_69.4.617.147","doi-asserted-by":"publisher","DOI":"10.1053\/snep.2001.21652"},{"key":"2025090723515854000_69.4.617.148","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08080715"},{"key":"2025090723515854000_69.4.617.149","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2015.06.005"},{"key":"2025090723515854000_69.4.617.150","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181de0c60"},{"key":"2025090723515854000_69.4.617.151","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2140"},{"key":"2025090723515854000_69.4.617.152","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204155"},{"key":"2025090723515854000_69.4.617.153","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.11.007"},{"key":"2025090723515854000_69.4.617.154","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2014.06.039"},{"key":"2025090723515854000_69.4.617.155","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12595"},{"key":"2025090723515854000_69.4.617.156","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1996.00440130066007"},{"key":"2025090723515854000_69.4.617.157","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.004"},{"key":"2025090723515854000_69.4.617.158","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0171-6"},{"key":"2025090723515854000_69.4.617.159","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3810\/pgm.2014.07.2786","article-title":"Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen\/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials","volume":"126","author":"Bello","year":"2014","journal-title":"Postgrad Med"},{"key":"2025090723515854000_69.4.617.160","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.010"},{"key":"2025090723515854000_69.4.617.161","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60673-3"},{"key":"2025090723515854000_69.4.617.162","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60749-1"},{"key":"2025090723515854000_69.4.617.163","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1756-185X.2010.01463.x","article-title":"Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis","volume":"13","author":"Cheung","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"2025090723515854000_69.4.617.164","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2011.625971"},{"key":"2025090723515854000_69.4.617.165","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12667"},{"key":"2025090723515854000_69.4.617.166","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50054"},{"key":"2025090723515854000_69.4.617.167","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.067"},{"key":"2025090723515854000_69.4.617.168","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-017-0081-6"},{"key":"2025090723515854000_69.4.617.169","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605303342204"},{"key":"2025090723515854000_69.4.617.170","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10382"},{"key":"2025090723515854000_69.4.617.171","first-page":"1","article-title":"Efficacy and tolerability of naproxen\/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses","volume":"5","author":"Datto","year":"2013","journal-title":"Open Access Rheumatol"},{"key":"2025090723515854000_69.4.617.172","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.325.7365.619","article-title":"Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials","volume":"325","author":"Deeks","year":"2002","journal-title":"BMJ"},{"key":"2025090723515854000_69.4.617.173","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.07.004"},{"key":"2025090723515854000_69.4.617.174","first-page":"CD012095","article-title":"Celecoxib for rheumatoid arthritis","volume":"6","author":"Fidahic","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090723515854000_69.4.617.175","first-page":"CD005115","article-title":"Rofecoxib for osteoarthritis","volume":"1","author":"Garner","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090723515854000_69.4.617.176","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0717-6"},{"key":"2025090723515854000_69.4.617.177","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12516"},{"key":"2025090723515854000_69.4.617.178","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03043.x"},{"key":"2025090723515854000_69.4.617.179","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.03.011"},{"key":"2025090723515854000_69.4.617.180","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328349de81"},{"key":"2025090723515854000_69.4.617.181","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13776"},{"key":"2025090723515854000_69.4.617.182","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199701000-00002"},{"key":"2025090723515854000_69.4.617.183","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.310"},{"key":"2025090723515854000_69.4.617.184","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07273-2"},{"key":"2025090723515854000_69.4.617.185","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2005.10.006"},{"key":"2025090723515854000_69.4.617.186","doi-asserted-by":"publisher","DOI":"10.1159\/000332211"},{"key":"2025090723515854000_69.4.617.187","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2015.98"},{"key":"2025090723515854000_69.4.617.188","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.03.049"},{"key":"2025090723515854000_69.4.617.189","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06143.x"},{"key":"2025090723515854000_69.4.617.190","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.154"},{"key":"2025090723515854000_69.4.617.191","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.11.020"},{"key":"2025090723515854000_69.4.617.192","doi-asserted-by":"publisher","DOI":"10.1155\/2005\/674607"},{"key":"2025090723515854000_69.4.617.193","first-page":"CD001961","article-title":"Initial management strategies for dyspepsia","volume":"2","author":"Delaney","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090723515854000_69.4.617.194","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2947"},{"key":"2025090723515854000_69.4.617.195","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.7193"},{"key":"2025090723515854000_69.4.617.196","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1605507"},{"key":"2025090723515854000_69.4.617.197","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-010-0334-1"},{"key":"2025090723515854000_69.4.617.198","doi-asserted-by":"publisher","DOI":"10.5056\/jnm15178"},{"key":"2025090723515854000_69.4.617.199","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0541-z"},{"key":"2025090723515854000_69.4.617.200","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00499.x"},{"key":"2025090723515854000_69.4.617.201","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01062.x"},{"key":"2025090723515854000_69.4.617.202","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-13-54","article-title":"Safety and efficacy of long-term esomeprazole 20 mg in Japanese patients with a history of peptic ulcer receiving daily non-steroidal anti-inflammatory drugs","volume":"13","author":"Sugano","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"2025090723515854000_69.4.617.203","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00686.x"},{"key":"2025090723515854000_69.4.617.204","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314010"},{"key":"2025090723515854000_69.4.617.205","doi-asserted-by":"publisher","DOI":"10.3310\/hta10200"},{"key":"2025090723515854000_69.4.617.206","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei241"},{"key":"2025090723515854000_69.4.617.207","first-page":"2203","article-title":"The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials","volume":"27","author":"Rostom","year":"2000","journal-title":"J Rheumatol"},{"key":"2025090723515854000_69.4.617.208","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00001"},{"key":"2025090723515854000_69.4.617.209","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88318-6"},{"key":"2025090723515854000_69.4.617.210","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.12.881"},{"key":"2025090723515854000_69.4.617.211","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13642"},{"key":"2025090723515854000_69.4.617.212","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381104"},{"key":"2025090723515854000_69.4.617.213","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381105"},{"key":"2025090723515854000_69.4.617.214","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1166-4"},{"key":"2025090723515854000_69.4.617.215","doi-asserted-by":"publisher","DOI":"10.1186\/ar2207"},{"key":"2025090723515854000_69.4.617.216","first-page":"461","article-title":"Screening for iron deficiency anemia, including iron supplementations for children and pregnant women: recommendation statement","volume":"74","year":"2006","journal-title":"Am Fam Physician"},{"key":"2025090723515854000_69.4.617.217","first-page":"1","article-title":"Recommendations to prevent and control iron deficiency in the United States","volume":"47","year":"1998","journal-title":"MMWR Recomm Rep"},{"key":"2025090723515854000_69.4.617.218","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181809c0d"},{"key":"2025090723515854000_69.4.617.219","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.4638"},{"key":"2025090723515854000_69.4.617.220","first-page":"98","article-title":"Iron deficiency anemia: evaluation and management","volume":"87","author":"Short","year":"2013","journal-title":"Am Fam Physician"},{"key":"2025090723515854000_69.4.617.221","first-page":"1117","article-title":"Evaluation of microcytosis","volume":"82","author":"Van Vranken","year":"2010","journal-title":"Am Fam Physician"},{"key":"2025090723515854000_69.4.617.222","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.228874"},{"key":"2025090723515854000_69.4.617.223","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32834f3140"},{"key":"2025090723515854000_69.4.617.224","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200506000-00005"},{"key":"2025090723515854000_69.4.617.225","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3552-x"},{"key":"2025090723515854000_69.4.617.226","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12858"},{"key":"2025090723515854000_69.4.617.227","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00603-2"},{"key":"2025090723515854000_69.4.617.228","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i31.4861"},{"key":"2025090723515854000_69.4.617.229","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13583"},{"key":"2025090723515854000_69.4.617.230","article-title":"Gastrointestinal bleeding: PPIs shown to exacerbate NSAID injury in rats through dysbiosis","volume":"8","author":"Thompson","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2025090723515854000_69.4.617.231","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.06.075"},{"key":"2025090723515854000_69.4.617.232","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000427"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2019-319300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:52:10Z","timestamp":1757314330000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2019-319300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":232,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,3,6]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/gutjnl-2019-319300"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2019-319300","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]}}}